HENKA

This brand name is authorized in Nigeria.

Active ingredients

The drug HENKA contains one active pharmaceutical ingredient (API):

1	Duloxetine UNII O5TNM5N07U - DULOXETINE
	Duloxetine is a combined serotonin (5-HT) and noradrenaline (NA) reuptake inhibitor. It weakly inhibits dopamine reuptake with no significant affinity for histaminergic, dopaminergic, cholinergic and adrenergic receptors.
	Read more about Duloxetine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100432	Prolonged-release capsule	HENKA 60 CAPSULE CAP_DR 60 mg 3x10	135 NF-PP-277123 HENKA 60 CAPSULE DULOXETINE DELAYED RELEASE CAPSULES USP 60MG DULOXETINE DELAYED RELEASE CAPSULES USP 60MG DRUGS Imported Products 310 Prescription Only Medicine (POM) 8/16/2022 HETERO LABS NIGERIA LIMITED, NO. 8B, WOLE OGUNJIMI STREET, AGBAOKU ESTATE, OFF OPEBI ROAD, IKEJA, LAGOS. HETERO LABS LIMITED, UNIT 1, KALYANPUR VILLAGE, CHAKKAN ROAD, BADDI DIST, SOLAN (H.P) INDIA, Nigeria	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX21	Duloxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100432